Siam

EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology

Retrieved on: 
Monday, December 19, 2022
Professional Services, Sustainability, Technology, Other Manufacturing, Environment, Green Technology, Engineering, Chemicals, Plastics, Biotechnology, Finance, Other Technology, Health, Manufacturing, Climate change, Engineering, Carbon footprint, Biotechnology, Biology, Enzyme, Nature, SEB, Sofinnova, Biochemistry, Siam, Multimedia, Venture round, World Economic Forum, Chemical engineering, KTH Royal Institute of Technology, Chemical industry, Investment, Renewable energy, Financial services, Industrifonden

EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round.

Key Points: 
  • EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round.
  • Its technology platform utilises nature’s catalysts, enzymes, combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.
  • “This fundraising marks a pivotal moment for EnginZyme," said Dr. Karim Engelmark Cassimjee, CEO and co-founder of EnginZyme.
  • By replacing traditional fossil-based manufacturing with the patented cell-free technology platform, EnginZyme seeks to accelerate the shift toward the sustainable biomanufacturing of products that modern society relies on.

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

Retrieved on: 
Monday, December 19, 2022
Enzyme, KTH Royal Institute of Technology, SEB, Sofinnova, Biochemistry, Nature, Venture round, World Economic Forum, Climate change, Engineering, Biotechnology, Investment, Chemical industry, Growth, Siam, Carbon footprint, Biology, Chemical engineering, Renewable energy, Industrifonden

Its technology platform utilises nature's catalysts, enzymes, combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.

Key Points: 
  • Its technology platform utilises nature's catalysts, enzymes, combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.
  • "This fundraising marks a pivotal moment for EnginZyme," said Dr Karim Engelmark Cassimjee, CEO and co-founder of EnginZyme.
  • With its science-based technology, solid industrial anchoring, and a strong syndicate of investors, EnginZyme is well positioned to accelerate the development of its technology for the benefit of sustainable manufacturing."
  • By replacing traditional fossil-based manufacturing with the patented cell-free technology platform, EnginZyme seeks to accelerate the shift toward the sustainable biomanufacturing of products that modern society relies on.

EnginZyme raises €21 million in Series B to accelerate the commercialisation of its cell-free biomanufacturing technology

Retrieved on: 
Monday, December 19, 2022
Enzyme, KTH Royal Institute of Technology, SEB, Sofinnova, Biochemistry, Nature, Venture round, World Economic Forum, Climate change, Engineering, Biotechnology, Investment, Chemical industry, Growth, Siam, Carbon footprint, Biology, Chemical engineering, Renewable energy, Industrifonden

Its technology platform utilises nature's catalysts, enzymes, combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.

Key Points: 
  • Its technology platform utilises nature's catalysts, enzymes, combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution.
  • "This fundraising marks a pivotal moment for EnginZyme," said Dr Karim Engelmark Cassimjee, CEO and co-founder of EnginZyme.
  • With its science-based technology, solid industrial anchoring, and a strong syndicate of investors, EnginZyme is well positioned to accelerate the development of its technology for the benefit of sustainable manufacturing."
  • By replacing traditional fossil-based manufacturing with the patented cell-free technology platform, EnginZyme seeks to accelerate the shift toward the sustainable biomanufacturing of products that modern society relies on.